These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 164530)

  • 41. 24-hour control of body temperature in the rat: II. Diisopropyl fluorophosphate-induced hypothermia and hyperthermia.
    Gordon CJ
    Pharmacol Biochem Behav; 1994 Nov; 49(3):747-54. PubMed ID: 7862732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of cycloheximide to alter rate of recovery of temperature following acute DFP treatment.
    Overstreet DH; Schiller GD; Day TA
    Eur J Pharmacol; 1977 Jul; 44(2):187-90. PubMed ID: 885167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of mu-opioid receptors in development of tolerance to diisopropylfluorophosphate (DFP).
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Toxicol Sci; 2005 Feb; 30(1):43-59. PubMed ID: 15800401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of DFP on iridic metabolism and release of acetylcholine and on pupillary function in the rat.
    Mattio TG; Richardson JS; Giacobini E
    Neuropharmacology; 1984 Oct; 23(10):1207-14. PubMed ID: 6521855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variation of commercial diisopropyl fluorophosphate preparations in toxicological studies.
    Ho IK; Hoskins B
    Drug Chem Toxicol; 1983; 6(5):421-7. PubMed ID: 6628264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.
    Melchers BP; van Helden HP
    Pharmacol Biochem Behav; 1990 Feb; 35(2):321-5. PubMed ID: 2157228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats.
    Kenley RA; Howd RA; Uyeno ET
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1001-8. PubMed ID: 7178195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective breeding for sensitivity to the anticholinesterase DFP.
    Overstreet DH; Russell RW; Helps SC; Messenger M
    Psychopharmacology (Berl); 1979 Sep; 65(1):15-20. PubMed ID: 116286
    [No Abstract]   [Full Text] [Related]  

  • 49. Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function.
    Terry AV; Buccafusco JJ; Gearhart DA; Beck WD; Middlemore-Risher ML; Truan JN; Schwarz GM; Xu M; Bartlett MG; Kutiyanawala A; Pillai A
    Neuroscience; 2011 Mar; 176():237-53. PubMed ID: 21185910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables.
    Russell RW; Overstreet DH; Messenger M; Helps SC
    Pharmacol Biochem Behav; 1982 Nov; 17(5):885-91. PubMed ID: 6891070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex differences following pharmacological manipulation of the cholinergic system by DFP and pilocarpine.
    Overstreet DH; Russell RW; Helps SC; Runge P; Prescott AM
    Psychopharmacology (Berl); 1979 Mar; 61(1):49-58. PubMed ID: 108719
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of ovariectomy on the sex-dependent effects of the anticholinesterase diisopropyl fluorophosphate.
    Overstreet DH; Russell RW; Kerni W; Netherton RA
    Psychopharmacology (Berl); 1981; 74(4):391-2. PubMed ID: 6794089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of locally administered anticholinesterase agents on the secretory response of human eccrine sweat glands to acetylcholine and carbachol.
    Longmore J; Jani B; Bradshaw CM; Szabadi E
    Br J Clin Pharmacol; 1986 Feb; 21(2):131-5. PubMed ID: 3954930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roles of neurotransmitter receptors in behavior: recovery of function following decreases in muscarinic receptor density induced by cholinesterase inhibition.
    Russell RW; Booth RA; Smith CA; Jenden DJ; Roch M; Rice KM; Lauretz SD
    Behav Neurosci; 1989 Aug; 103(4):881-92. PubMed ID: 2765189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate.
    Lim DK; Porter AB; Hoskins B; Ho IK
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):477-89. PubMed ID: 3660414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced behavioral effects of pilocarpine during chronic treatment with DFP.
    Overstreet DH
    Behav Biol; 1974 May; 11(1):49-58. PubMed ID: 4833225
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes of acetylcholinesterase activity in three major brain areas and related changes in behaviour following acute treatment with diisopropyl fluorophosphate.
    Kozar MD; Overstreet DH; Chippendale TC; Russell RW
    Neuropharmacology; 1976 May; 15(5):291-8. PubMed ID: 934442
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of acetylcholinesterase in the gut inhibits schedule-controlled behavior in the rat.
    Brezenoff HE; McGee J; Hymowitz N
    Life Sci; 1985 Jul; 37(1):49-54. PubMed ID: 4010469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rat brain acetylcholinesterase.
    Volpe MT; Bisso GM; Michalek H
    Neurochem Res; 1990 Oct; 15(10):975-9. PubMed ID: 2077431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
    Ramachandran BV
    Biochem Pharmacol; 1967 Nov; 16(11):2061-8. PubMed ID: 4229543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.